Recently, a DESI-MS system as well as extraction nanoelectrospray ionization were successfully tested for intraoperative identification of IDH mutation status by measuring ion intensities of 2-hydroxyglutarate (2-HG) from tumor cores [20,21,22,23]. The gene discussed is IDH2; the disease is neoplasm.